Adaptive Biotechnologies News

Adaptive Biotechnologies Analyst Ratings

BenzingaDec 18 10:54 ET · Ratings

BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $9

Moomoo NewsDec 18 07:34 ET · Ratings

Adaptive Biotechnologies Gains Positive Outlook With Strategic Advancements and Increased ClonoSEQ Utilization

TipRanksDec 18 06:45 ET

Top 3 Health Care Stocks That May Collapse This Quarter

BenzingaDec 11 06:55 ET

Even After Rising 6.5% This Past Week, Adaptive Biotechnologies (NASDAQ:ADPT) Shareholders Are Still Down 77% Over the Past Five Years

Simply Wall StDec 11 06:19 ET

CAR T-cell Therapy Strategic Business Research Report 2024-2030: Allogeneic `Off-the-Shelf` CAR T-Cell Therapies Generate New Opportunities in Manufacturing - ResearchAndMarkets.com

BusinesswireDec 4 08:47 ET

Express News | Adaptive Biotechnologies Announces Over 65 Abstracts Featuring Clonoseq® Mrd Testing Across a Range of Blood Cancers to Be Presented at the 66TH Ash Annual Meeting

ReutersDec 3 07:30 ET

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring ClonoSEQ MRD Testing Across a Range of Blood Cancers to Be Presented at the 66th ASH Annual Meeting

GlobeNewswireDec 3 07:30 ET

Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?

BenzingaNov 26 22:37 ET

Morgan Stanley Maintains Adaptive Biotechnologies(ADPT.US) With Hold Rating, Maintains Target Price $7

Moomoo NewsNov 19 03:36 ET · Ratings

Balanced Hold Recommendation for Adaptive Biotechnologies Amid Positive Performance and External Challenges

TipRanksNov 18 20:47 ET · Ratings

Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness

Seeking AlphaNov 15 15:55 ET

Scotiabank Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 12 07:36 ET · Ratings

Adaptive Biotechnologies Corporation's (NASDAQ:ADPT) 31% Jump Shows Its Popularity With Investors

Simply Wall StNov 12 06:30 ET

Adaptive Biotechnologies Is Maintained at Overweight by Piper Sandler

Dow JonesNov 11 08:00 ET · Ratings

Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $7

Moomoo NewsNov 11 07:31 ET · Ratings

J.P. Morgan Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $7

Moomoo NewsNov 11 07:31 ET · Ratings

Express News | Adaptive Biotechnologies Corp : Piper Sandler Raises Target Price to $7 From $6

ReutersNov 10 23:14 ET

Q3 2024 Adaptive Biotechnologies Corp Earnings Call

Yahoo FinanceNov 8 10:18 ET

TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating

Moomoo NewsNov 8 01:31 ET · Ratings